| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,935.35
|
|
Change (%)
|
-4.65 (-0.24%)
|
|
Best Buy (RS)
|
1932.5(x5)
|
|
Best Sell (RS)
|
1935.05(x12)
|
|
Today's Range (RS)
|
1,927.05
-
1,944.75
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.46
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
| Sun Pharma gets nod for Semaglutide injection in South Africa |
| Barometers trade higher; private bank shares jump |
| Sun Pharmaceuticals Industries announces board meeting date |
| Sun Pharmaceutical Industries Ltd spurts 0.07%, up for five straight sessions |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
04-Aug-2026 |
1960.00 |
-1.02 |
| 1Month |
13-Jul-2026 |
1924.05 |
0.83 |
| 3Month |
11-May-2026 |
1872.40 |
3.61 |
| 6Month |
11-Feb-2026 |
1710.65 |
13.41 |
| 1Year |
11-Aug-2025 |
1612.60 |
20.30 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.88 |
4066.76 |
| SBI BSE SENSEX ETF |
2.31 |
2843.23 |
| ICICI Pru Value Fund |
4.49 |
2740.90 |
| ICICI Pru Equity & Debt Fund |
3.74 |
1961.25 |
| ICICI Pru Large Cap Fund |
2.23 |
1805.14 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,459.00 |
-0.21 |
1,672.20 |
1,165.55 |
118,106.99 |
| Zydus Lifesciences Ltd |
1,200.20 |
1.71 |
1,205.00 |
835.85 |
117,705.45 |
| Lupin Ltd |
2,256.00 |
-0.97 |
2,530.00 |
1,881.80 |
104,157.57 |
| Dr Reddys Laboratories Ltd |
1,199.85 |
-0.43 |
1,414.40 |
1,080.05 |
100,578.43 |
| Laurus Labs Ltd |
1,839.20 |
-1.12 |
1,870.00 |
810.75 |
100,498.07 |
|
|
|
|